Malignant Pleural Mesothelioma
📧 Sign up to get email alerts when something new happens for Malignant Pleural Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology
A not-yet-recruiting trial from University of Kansas Medical Center aims to comprehensively map oncogenomic profiles in thoracic and head-an…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
A National Cancer Institute-supported clinical trial is evaluating cell changes in blood and tissue for cancers of the lung, esophagus, and …
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating dual-target MSLN/FAP CAR-NK cells for malignant pleural and peritoneal mesothelioma; the study is c…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma [Phase 3]
This entry notes a Phase 3 trial evaluating MEDI5752 in combination with carboplatin and pemetrexed for unresectable malignant pleural mesot…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma [NA]
A clinical trial evaluating hemithoracic irradiation using proton therapy in malignant pleural mesothelioma. The study is currently recruiti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors [Phase 2]
A Phase 2 clinical trial evaluating Volrustomig as monotherapy or in combination with anti-cancer agents across multiple advanced/metastatic…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma [Phase 1]
Phase 1 study evaluating pembrolizumab in combination with radiation therapy for malignant pleural mesothelioma; the trial is currently not …
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Short Neoadjuvant Hemithoracic IMRT for MPM [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating short neoadjuvant hemithoracic IMRT for malignant pleural mesothelioma.
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: From Presentation to Diagnosis: Patterns of Pleural Effusion
A completed clinical trial update from Mansoura University Hospital examining patterns of pleural effusion in malignant pleural mesothelioma…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma [Phase 2]
A Phase 2 clinical trial evaluating intrapleural photodynamic therapy as part of multimodal treatment for malignant pleural mesothelioma has…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma [Phase 1]
A Phase 1 trial evaluating pembrolizumab in combination with hypofractionated stereotactic radiotherapy for advanced malignant pleural mesot…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma [Phase 3]
Phase 3 trial evaluating durvalumab with chemotherapy as first-line therapy for advanced malignant pleural mesothelioma has completed.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma [NA]
Clinical trial NCT03269227 assessing accelerated hypofractionated radiotherapy for malignant pleural mesothelioma is currently active but no…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Study of the Efficacy and Safety of the Bintrafusp Alfa in Previously Treated Advanced Malignant Pleural Mesothelioma [Phase 2]
Phase 2 trial evaluating the efficacy and safety of bintrafusp alfa in previously treated advanced malignant pleural mesothelioma has comple…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers [NA]
A Dana-Farber Cancer Institute-led trial is recruiting to validate prognostic biomarkers for malignant pleural mesothelioma using prospectiv…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM) [Phase 1]
This clinical trial update notes a Phase 1 study evaluating pembrolizumab in combination with chemotherapy and image-guided surgery for mali…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]
Clinical trial update reports the completion of a Phase 1/2 safety and efficacy study of CTX131 in adults with relapsed or refractory solid …
-
CLINICAL_TRIALS trial_result · 2025-11-13Clinical Trial Update: Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma [Phase 1]
A Phase 1 clinical trial evaluating pembrolizumab after radiation therapy in patients with malignant pleural mesothelioma. Results were post…
-
CLINICAL_TRIALS trial_result · 2025-10-22Clinical Trial Update: Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma [Phase 1]
A Phase 1 clinical trial evaluating stereotactic body radiation therapy in combination with immunotherapy for malignant pleural mesothelioma…
-
FDA approval · 2025-10-09FDA Approved: PEMETREXED — Supplemental Application (Waverley Pharma Inc)
FDA approved a supplemental application for pemetrexed disodium by Waverley Pharma Inc, resulting in updated approval/label for the generic …
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating autologous T cells engineered to target mesothelin in malignant pleural mesothelioma. The study is …
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)
This clinical trial update reports the completion of an observational study of nivolumab plus ipilimumab in patients with previously unresec…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: The IMmunotherapy Pleural 5-ALA PDT [Phase 2]
Phase 2 clinical trial evaluating 5-ALA photodynamic therapy for malignant pleural mesothelioma; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma [NA]
A clinical trial is evaluating the use of electronic nose (E-Nose) technology to measure treatment response in malignant pleural mesotheliom…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma [Phase 2]
A Phase 2 trial of nintedanib as switch maintenance therapy for malignant pleural mesothelioma has been terminated.